Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05621369Recruiting

Psorcast Mobile Study

Role: lead

NCT02696603Not ApplicableActive Not Recruiting

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)

Role: lead

NCT03538262Completed

Assessing Tele-Health Outcomes in Multiyear Extensions of PD Trials

Role: collaborator

NCT03006653Completed

Understanding Daily Fluctuations in Self-Regulation

Role: collaborator

NCT03248869Not ApplicableCompleted

Asthma Mobile Health Application 2.0

Role: collaborator

All 5 trials loaded